• Теги
    • избранные теги
    • Компании2137
      • Показать ещё
      Разное483
      • Показать ещё
      Страны / Регионы446
      • Показать ещё
      Международные организации36
      • Показать ещё
      Показатели36
      • Показать ещё
      Формат24
      Люди56
      • Показать ещё
      Издания23
      • Показать ещё
Выбор редакции
26 мая, 15:08

Pharma Stock Roundup: Label Expansion for Merck Drug, Aerie Up On Eye Data

Merck (MRK) got another approval for Keytruda while Aerie shot up on positive data.

24 мая, 17:28

AstraZeneca's Bydureon Fails to Reduce Cardiovascular Risk

AstraZeneca plc (AZN) announced top-line results from the EXSCEL study evaluating the cardiovascular (CV) safety profile of its type II diabetes drug Bydureon.

24 мая, 16:30

The Zacks Analyst Blog Highlights: Oracle, Chubb, AstraZeneca, Estee Lauder and Aflac

The Zacks Analyst Blog Highlights: Oracle, Chubb, AstraZeneca, Estee Lauder and Aflac

23 мая, 23:05

New Research Reports for Oracle, Chubb, AstraZeneca & Others

New Research Reports for Oracle, Chubb, AstraZeneca & Others

23 мая, 17:33

AstraZeneca Sells Marketing Rights to Seloken in Europe

AstraZeneca plc (AZN) announced that it has signed an agreement with Recordati S.p.A, granting commercial rights to Seloken/Seloken ZOK and associated Logimax fixed-dose combination to the latter in European markets.

Выбор редакции
23 мая, 15:31

AstraZeneca PLC (AZN): Strong Industry, Solid Earnings Estimate Revisions

AstraZeneca (AZN) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.

Выбор редакции
22 мая, 23:46

Astrazeneca (AZN) Gets Positive CHMP Opinion for Brodalumab

Astrazeneca PLC (AZN) and its partner LEO Pharma received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA).

Выбор редакции
Выбор редакции
22 мая, 18:26

AstraZeneca sells Seloken European rights for $300m

Anglo-Swedish group to make and supply beta-blocker to Italian drugmaker Recordati

22 мая, 15:58

Clovis' (CLVS) PARP Inhibtor Shows Promise, Risks Remain

On May 19, we issued an updated research report on Boulder, CO based Clovis Oncology, Inc. (CLVS).

Выбор редакции
Выбор редакции
Выбор редакции
19 мая, 14:43

Pharma Stock Roundup: J&J's Pharma Pipeline Update, Shire's HAE Data & More

This week, industry bellwether J&J (JNJ) provided a look at its pharma pipeline while Shire was up on HAE data.

19 мая, 00:10

Endocyte (ECYT) Focused on Two Lead Pipeline Candidates

We issued an updated report on Endocyte, Inc. (ECYT) on May 17.

Выбор редакции
Выбор редакции
Выбор редакции
15 мая, 17:40

Company News for May 15, 2017

Companies in the News are: JWN,ADR,GLW,AAPL,TTD